Intracerebroventricular norepinephrine potentiation of the perforant path-evoked potential in dentate gyrus of anesthetized and awake rats: A role for both alpha- and beta-adrenoceptor activation.
Norepinephrine (NE) applied iontophoretically to the dentate gyrus in vivo, and bath applied to hippocampal slices in vitro, produces potentiation of the perforant path-evoked potential. beta-receptors mediate exogenous NE potentiation in vitro, while alpha-receptors are implicated in exogenous effects in vivo. The present study uses intracerebroventricular (i.c.v.) NE to mimic in vitro bath conditions in vivo. Short-term NE potentiation was reliably seen with 10 microg [+/-] NE in 2 microl of 0.9% saline i.c.v. Long-term potentiation occurred with higher doses of NE. The beta-agonist isoproterenol and the alpha-agonist phenylephrine also produced potentiation. Long-term effects were common with isoproterenol. The beta-antagonist metoprolol and the alpha-antagonist phentolamine attenuated NE potentiation. The results suggest that both alpha- and beta-receptors could play a role in NE potentiation in dentate gyrus in vivo. In awake animals, 10 microg NE i.c.v. reproduced the potentiation pattern seen in anesthetized rats. NE potentiation in awake rats was independent of behavioral variation.
Chaulk
P C
PC
Department of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Harley
C W
CW
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000777:Anesthetics; D000818:Animals; D018891:Dentate Gyrus / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D007276:Injections, Intraventricular; D007545:Isoproterenol / Q000494:pharmacology; D019580:Perforant Pathway / Q000187:drug effects*; D010656:Phenylephrine / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014851:Wakefulness
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D010656:Phenylephrine; D007545:Isoproterenol